Release Date: 29/07/11 09:06 Summary: June 2011 Quarterly Activities and Cash Flow Reports Price Sensitive: Yes Download Document 354.56KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%